Shots: The US FDA has accepted the BLA for toripalimab + CT (gemcitabine & cisplatin) & toripalimab as monothx. to treat advanced recurrent or metastatic NPC after platinum-containing CT. The […]readmore
Tags : Nasopharyngeal Carcinoma
Shots: The designation is based on the P-III JUPITER-02 trial evaluating toripalimab + CT vs CT alone in patients with NPC. The result was presented at ASCO 2021 The results […]readmore
Shots: The US FDA has granted the BTD for Toripalimab to treat nasopharyngeal carcinoma. The BTD will allow the company to work with the FDA to bring the therapy to […]readmore